InsiderTrades.com logo

VYNE Insider Trading

Insider Ownership Percentage: 3.03%
Insider Buying (Last 12 Months): $43,800.00
Insider Selling (Last 12 Months): $0.00

VYNE Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at VYNE Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

VYNE Therapeutics Share Price & Price History

Current Price: $0.37
Price Change: ▼ Price Decrease of -0.0005 (-0.13%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for VYNE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

VYNE Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/15/2025Patrick G LePoreDirectorBuy15,000$2.92$43,800.0051,472View SEC Filing Icon  
11/15/2023Patrick G LePoreDirectorBuy13,000$3.91$50,830.0036,472View SEC Filing Icon  
3/20/2023Mutya HarschInsiderBuy10,000$2.50$25,000.0022,721View SEC Filing Icon  
3/20/2023Patrick G LePoreDirectorBuy20,000$2.48$49,600.0023,472View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for VYNE Therapeutics (NASDAQ:VYNE)

83.78% of VYNE Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VYNE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

VYNE Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Acorn Capital Advisors LLC586,572$0.20M0.1%-20.4%1.762%Search for SEC Filing on Google Icon
11/17/2025Baker BROS. Advisors LP851,353$0.29M0.0%N/A2.557%Search for SEC Filing on Google Icon
11/14/2025Shay Capital LLC492,577$0.17M0.0%N/A1.934%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP220,788$74K0.0%N/A0.867%Search for SEC Filing on Google Icon
8/15/2025Exome Asset Management LLC208,970$0.35M0.2%-54.8%1.374%Search for SEC Filing on Google Icon
8/15/2025Boothbay Fund Management LLC106,459$0.18M0.0%N/A0.700%Search for SEC Filing on Google Icon
8/15/2025Acorn Capital Advisors LLC736,572$1.22M0.8%-6.3%4.843%Search for SEC Filing on Google Icon
8/15/2025Adage Capital Partners GP L.L.C.644,134$1.06M0.0%+87.2%4.235%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC124,822$0.21M0.0%N/A0.821%Search for SEC Filing on Google Icon
8/14/2025TFG Asset Management GP Ltd115,384$0.19M0.0%N/A0.759%Search for SEC Filing on Google Icon
8/14/2025Velan Capital Investment Management LP30,000$50K0.0%N/A0.197%Search for SEC Filing on Google Icon
8/13/2025Kennedy Capital Management LLC570,740$0.94M0.0%N/A3.752%Search for SEC Filing on Google Icon
8/11/2025Patient Square Capital LP317,033$0.52M0.2%+23.3%2.084%Search for SEC Filing on Google Icon
5/19/2025Acorn Capital Advisors LLC785,938$1.24M0.8%+72.0%5.167%Search for SEC Filing on Google Icon
5/16/2025Exome Asset Management LLC462,801$0.73M0.6%+30.9%3.043%Search for SEC Filing on Google Icon
5/16/2025Parkman Healthcare Partners LLC217,978$0.34M0.0%+42.5%1.433%Search for SEC Filing on Google Icon
5/16/2025Adage Capital Partners GP L.L.C.344,134$0.54M0.0%+123.3%2.263%Search for SEC Filing on Google Icon
5/16/2025ADAR1 Capital Management LLC70,419$0.11M0.0%N/A0.463%Search for SEC Filing on Google Icon
5/15/2025DAFNA Capital Management LLC636,103$1.01M0.3%N/A4.182%Search for SEC Filing on Google Icon
5/12/2025Virtu Financial LLC19,574$31K0.0%N/A0.129%Search for SEC Filing on Google Icon
5/8/2025XTX Topco Ltd33,052$52K0.0%+57.3%0.217%Search for SEC Filing on Google Icon
2/17/2025Parkman Healthcare Partners LLC152,973$0.51M0.1%-24.6%1.037%Search for SEC Filing on Google Icon
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC245,800$0.82M0.1%N/A1.666%Search for SEC Filing on Google Icon
2/17/2025Bridgeway Capital Management LLC36,958$0.12M0.0%N/A0.251%Search for SEC Filing on Google Icon
2/17/2025Acorn Capital Advisors LLC456,970$1.53M0.8%N/A3.098%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC20,286$68K0.0%N/A0.138%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC176,658$0.59M0.0%+4.8%1.198%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp23,971$80K0.0%-35.7%0.163%Search for SEC Filing on Google Icon
2/14/2025Adage Capital Partners GP L.L.C.154,134$0.52M0.0%N/A1.045%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd21,018$70K0.0%N/A0.142%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC24,943$84K0.0%-71.2%0.169%Search for SEC Filing on Google Icon
11/15/2024Parkman Healthcare Partners LLC202,973$0.38M0.0%-41.2%1.376%Search for SEC Filing on Google Icon
10/30/2024AlphaCentric Advisors LLC268,485$0.51M0.4%-13.5%1.820%Search for SEC Filing on Google Icon
8/15/2024Lynx1 Capital Management LP16,194$32K0.0%N/A0.111%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC63,111$0.12M0.0%-21.7%0.434%Search for SEC Filing on Google Icon
7/26/2024AlphaCentric Advisors LLC310,500$0.61M0.5%-30.2%2.137%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC16,199$50K0.0%N/A0.112%Search for SEC Filing on Google Icon
2/20/2024Eventide Asset Management LLC1,394,336$3.25M0.1%N/A9.988%Search for SEC Filing on Google Icon
2/15/2024Parkman Healthcare Partners LLC696,470$1.62M0.2%N/A4.990%Search for SEC Filing on Google Icon
5/15/2023DSC Advisors L.P.115,000$0.35M0.3%-92.7%3.523%Search for SEC Filing on Google Icon
5/10/2023Staley Capital Advisers Inc.23,472$72K0.0%-62.4%0.720%Search for SEC Filing on Google Icon
10/7/2022Mackenzie Financial Corp134,920$30K0.0%+106.8%0.233%Search for SEC Filing on Google Icon
4/25/2022Bailard Inc.139,381$91K0.0%N/A0.248%Search for SEC Filing on Google Icon
2/15/2022DSC Advisors L.P.2,551,000$2.60M2.0%+131.9%4.767%Search for SEC Filing on Google Icon
2/14/2022Perceptive Advisors LLC2,178,022$2.22M0.0%-6.5%4.070%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP217,747$0.22M0.0%+135.7%0.407%Search for SEC Filing on Google Icon
1/24/2022SkyOak Wealth LLC27,200$28K0.0%N/A0.051%Search for SEC Filing on Google Icon
12/3/2021Perceptive Advisors LLC2,330,471$3.24M0.0%-59.6%4.355%Search for SEC Filing on Google Icon
11/16/2021Thrivent Financial for Lutherans71,990$0.10M0.0%+20.2%0.140%Search for SEC Filing on Google Icon
11/15/2021683 Capital Management LLC715,386$0.99M0.0%-2.5%1.389%Search for SEC Filing on Google Icon
11/15/2021Healthcare Value Capital LLC400,000$0.56M1.1%-11.1%0.777%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.1,921,236$2.67M0.0%+1.1%3.730%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP92,402$0.13M0.0%N/A0.179%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC1,245,027$1.73M0.0%+300.4%2.417%Search for SEC Filing on Google Icon
11/5/2021Staley Capital Advisers Inc.50,000$70K0.0%+33.3%0.097%Search for SEC Filing on Google Icon
10/29/2021Banque Cantonale Vaudoise80,000$0.11M0.0%-60.0%0.155%Search for SEC Filing on Google Icon
9/24/2021Thrivent Financial for Lutherans59,884$0.21M0.0%N/A0.116%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD40,050$0.14M0.0%+23.5%0.078%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
VYNE Therapeutics logo
VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary and therapeutics for the treatment of immuno-inflammatory conditions. The company's lead product is VYN201, a locally administered pan- bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways with low systemic exposure. It also develops VYN202, a BD2-selective oral small molecule BET inhibitor for the treatment of immuno-inflammatory indications. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.
Read More on VYNE Therapeutics

Today's Range

Now: $0.37
Low: $0.37
High: $0.38

50 Day Range

MA: $0.36
Low: $0.32
High: $0.43

52 Week Range

Now: $0.37
Low: $0.28
High: $4.30

Volume

395,339 shs

Average Volume

1,157,707 shs

Market Capitalization

$12.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.99

Who are the company insiders with the largest holdings of VYNE Therapeutics?

VYNE Therapeutics' top insider investors include:
  1. Patrick G Lepore (Director)
Learn More about top insider investors at VYNE Therapeutics.

Who are the major institutional investors of VYNE Therapeutics?

VYNE Therapeutics' top institutional shareholders include:
  1. Baker BROS. Advisors LP — 2.56%
  2. Acorn Capital Advisors LLC — 1.76%
  3. Shay Capital LLC — 1.93%
  4. Two Sigma Investments LP — 0.87%
Learn More about top institutional investors of VYNE Therapeutics stock.

Which major investors are selling VYNE Therapeutics stock?

Within the previous quarter, VYNE stock was sold by these institutional investors:
  1. Acorn Capital Advisors LLC

Which major investors are buying VYNE Therapeutics stock?

Within the previous quarter, VYNE stock was bought by institutional investors including:
  1. Baker BROS. Advisors LP
  2. Shay Capital LLC
  3. Two Sigma Investments LP